| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Section of Infectious Diseases and
Mass Spectrometry Resource, Boston University School of Medicine, Boston, MA 02118;
Children’s Hospital Oakland Research Institute, Oakland, CA 94609;
Department of Biochemistry, Trinity College, Dublin, Ireland;
¶ Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605; and
|| Institut für Hygiene und Mikrobiologie, Universität Würzburg, Würzburg, Germany
Neisseria meningitidis binds factor H (fH), a key regulator of the alternative complement pathway. A 
29 kD fH-binding protein expressed in the meningococcal outer membrane was identified by mass spectrometry as GNA1870, a lipoprotein currently under evaluation as a broad-spectrum meningococcal vaccine candidate. GNA1870 was confirmed as the fH ligand on intact bacteria by 1) abrogation of fH binding upon deleting GNA1870, and 2) blocking fH binding by anti-GNA1870 mAbs. fH bound to whole bacteria and purified rGNA1870 representing each of the three variant GNA1870 families. We showed that the amount of fH binding correlated with the level of bacterial GNA1870 expression. High levels of variant 1 GNA1870 expression (either by allelic replacement of gna1870 or by plasmid-driven high-level expression) in strains that otherwise were low-level GNA1870 expressers (and bound low amounts of fH by flow cytometry) restored high levels of fH binding. Diminished fH binding to the GNA1870 deletion mutants was accompanied by enhanced C3 binding and increased killing of the mutants. Conversely, high levels of GNA1870 expression and fH binding enhanced serum resistance. Our findings support the hypothesis that inhibiting the binding of a complement down-regulator protein to the neisserial surface by specific Ab may enhance intrinsic bactericidal activity of the Ab, resulting in two distinct mechanisms of Ab-mediated vaccine efficacy. These data provide further support for inclusion of this molecule in a meningococcal vaccine. To reflect the critical function of this molecule, we suggest calling it fH-binding protein.
This article has been cited by other articles:
|
|
 |
|
  J. Lucidarme, M. Comanducci, J. Findlow, S. J. Gray, E. B. Kaczmarski, M. Guiver, E. Kugelberg, P. J. Vallely, P. Oster, M. Pizza, et al. Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales J. Clin. Microbiol., November 1, 2009; 47(11): 3577 - 3585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Beernink and D. M. Granoff The modular architecture of meningococcal factor H-binding protein Microbiology, September 1, 2009; 155(9): 2873 - 2883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Plested, J. A. Welsch, and D. M. Granoff Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity Clin. Vaccine Immunol., June 1, 2009; 16(6): 785 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fantappie, M. M. E. Metruccio, K. L. Seib, F. Oriente, E. Cartocci, F. Ferlicca, M. M. Giuliani, V. Scarlato, and I. Delany The RNA Chaperone Hfq Is Involved in Stress Response and Virulence in Neisseria meningitidis and Is a Pleiotropic Regulator of Protein Expression Infect. Immun., May 1, 2009; 77(5): 1842 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shaughnessy, L. A. Lewis, H. Jarva, and S. Ram Functional Comparison of the Binding of Factor H Short Consensus Repeat 6 (SCR 6) to Factor H Binding Protein from Neisseria meningitidis and the Binding of Factor H SCR 18 to 20 to Neisseria gonorrhoeae Porin Infect. Immun., May 1, 2009; 77(5): 2094 - 2103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cantini, D. Veggi, S. Dragonetti, S. Savino, M. Scarselli, G. Romagnoli, M. Pizza, L. Banci, and R. Rappuoli Solution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidis J. Biol. Chem., April 3, 2009; 284(14): 9022 - 9026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mascioni, B. E. Bentley, R. Camarda, D. A. Dilts, P. Fink, V. Gusarova, S. K. Hoiseth, J. Jacob, S. L. Lin, K. Malakian, et al. Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086 J. Biol. Chem., March 27, 2009; 284(13): 8738 - 8746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Granoff, J. A. Welsch, and S. Ram Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera Infect. Immun., February 1, 2009; 77(2): 764 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Koeberling, S. Giuntini, A. Seubert, and D. M. Granoff Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2 Clin. Vaccine Immunol., February 1, 2009; 16(2): 156 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Seib, D. Serruto, F. Oriente, I. Delany, J. Adu-Bobie, D. Veggi, B. Arico, R. Rappuoli, and M. Pizza Factor H-Binding Protein Is Important for Meningococcal Survival in Human Whole Blood and Serum and in the Presence of the Antimicrobial Peptide LL-37 Infect. Immun., January 1, 2009; 77(1): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Friberg, P. Carlson, E. Kentala, P. S. Mattila, P. Kuusela, S. Meri, and H. Jarva Factor H Binding as a Complement Evasion Mechanism for an Anaerobic Pathogen, Fusobacterium necrophorum J. Immunol., December 15, 2008; 181(12): 8624 - 8632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Beernink, J. A. Welsch, M. Bar-Lev, O. Koeberling, M. Comanducci, and D. M. Granoff Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein Infect. Immun., September 1, 2008; 76(9): 4232 - 4240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. T. Beernink and D. M. Granoff Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines Infect. Immun., June 1, 2008; 76(6): 2568 - 2575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ngampasutadol, S. Ram, S. Gulati, S. Agarwal, C. Li, A. Visintin, B. Monks, G. Madico, and P. A. Rice Human Factor H Interacts Selectively with Neisseria gonorrhoeae and Results in Species-Specific Complement Evasion J. Immunol., March 1, 2008; 180(5): 3426 - 3435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Lewis, S. Ram, A. Prasad, S. Gulati, S. Getzlaff, A. M. Blom, U. Vogel, and P. A. Rice Defining Targets for Complement Components C4b and C3b on the Pathogenic Neisseriae Infect. Immun., January 1, 2008; 76(1): 339 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Welsch and D. Granoff Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal Antibody Clin. Vaccine Immunol., December 1, 2007; 14(12): 1596 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Findlow, A. Holland, D. Martin, P. Oster, P. Balmer, and R. Borrow Inadequacy of Colominic Acid as an Absorbent Intended To Facilitate Use of Complement-Preserved Baby Rabbit Serum in the Neisseria meningitidis Serogroup B Serum Bactericidal Antibody Assay Clin. Vaccine Immunol., May 1, 2007; 14(5): 556 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Madico, J. Ngampasutadol, S. Gulati, U. Vogel, P. A. Rice, and S. Ram Factor H Binding and Function in Sialylated Pathogenic Neisseriae is Influenced by Gonococcal, but Not Meningococcal, Porin J. Immunol., April 1, 2007; 178(7): 4489 - 4497. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
